Logo
Jalupro Glow Peel 5ml vials

Jalupro Glow Peel 5ml vials

Jalupro

Aesthetic medicine
  • Marketed as a professional cosmetic/chemical peel with CE marking in the cosmetics category in the European Community.
  • Manufactured by Professional Derma SA under appropriate cosmetic and medical Aesthetic quality management systems (e.g. ISO 22716 / ISO 13485 where applicable).
  • Intended exclusively for professional use, in compliance with EU/UK cosmetic regulations and local professional practice standards.
Chemical peel / topical amino acid replacement therapy

Description

Jalupro Glow Peel is an innovative, professional chemical peel based on an advanced acid blend combined with Jalupro’s signature amino acid complex. Supplied as multiple 5 ml vials, it is designed to treat chrono- and photo-ageing, fine lines, wrinkles, pigmentation disorders, acne and acne scarring, and overall dull or uneven skin. The peel gently but effectively exfoliates the epidermis, stimulates cell turnover and collagen production, and promotes biorevitalisation of the skin. It can be used on the face, neck, décolleté, hands and other body areas, delivering a brighter, smoother, more even-toned and youthful complexion with minimal downtime. Jalupro Glow Peel is suitable for all skin types when applied by trained professionals and can be incorporated into comprehensive aesthetic treatment plans.

Bnefits

  • Targets chrono- and photo-ageing, helping to reduce fine lines, wrinkles and loss of elasticity.
  • Improves skin tone and texture, promoting smoother, brighter and more even-looking skin.
  • Helps reduce hyperpigmentation, sun spots and post-inflammatory pigmentation.
  • Improves the appearance of acne and acne scars while helping to calm inflammatory lesions.
  • Stimulates cell renewal and collagen production through a synergy of chemical exfoliation and amino acid support.
  • Provides biorevitalisation benefits, supporting long-term skin health, firmness and elasticity.
  • Suitable for use on face, neck, décolleté, hands and selected body areas.
  • Clinically supported effectiveness with visible results and generally minimal downtime.
  • Designed to be comfortable and relatively pain-free compared with more aggressive peels.
  • Can be combined with other aesthetic procedures as part of a 360° skin rejuvenation programme.

Indications

  • Chronological and photo-induced skin ageing of the face and body (mild to moderate).
  • Fine lines and superficial wrinkles.
  • Uneven skin tone and texture, including dull or rough skin.
  • Epidermal hyperpigmentation and dyschromia such as sun spots and some forms of melasma (according to practitioner judgement).
  • Acne-prone skin with superficial scars and post-inflammatory marks.
  • Biorevitalisation and brightening of face, neck, décolleté, hands and other indicated body areas.
  • Adjunctive treatment within a broader aesthetic plan (e.g. in between injectables, microneedling, or device-based therapies).

Composition

  • Mandelic acid – alpha hydroxy acid (AHA) with medium molecular weight, provides controlled epidermal exfoliation and helps improve texture, pigmentation and acne.
  • Lactic acid – AHA that gently exfoliates, hydrates and brightens the skin.
  • Salicylic acid – beta hydroxy acid (BHA) with keratolytic and comedolytic properties, useful for acne-prone and congested skin.
  • Tranexamic acid – helps reduce hyperpigmentation and post-inflammatory erythema, supporting a more even tone.
  • Resorcinol – exfoliating and pigment-modulating agent that enhances peeling efficacy.
  • Amino acid complex – Jalupro amino acid cluster (e.g. glycine, L-proline, L-leucine, L-lysine and related amino acids) to support fibroblast activity and collagen synthesis.
  • Excipients and solvents suitable for a professional peel solution (buffering agents, stabilisers and vehicle components as detailed in the official IFU).
  • Note: a previous version contained the blue dye CI 42090, which has been removed; the current solution is colourless or slightly yellowish according to manufacturer declaration.

Formulation

  • Professional-use, liquid chemical peel solution in multi-dose glass vials (5 ml each).
  • Synergistic blend of AHAs, BHA, tranexamic acid and resorcinol combined with Jalupro amino acid technology (topical Amino Acid Replacement Therapy).
  • Formulated to provide controlled, medium-depth epidermal exfoliation with biorevitalising and brightening activity.
  • Topical use only; non-neutralising peel that may be followed by post-peel care according to protocol.

Packaging

  • Standard pack: 6 vials x 5 ml per box.
  • Each glass vial contains 5 ml of ready-to-use Jalupro Glow Peel solution.
  • Outer carton printed with product name, brand, batch number, expiry date, storage conditions and regulatory markings.
  • Professional-only packaging with instructions for use provided in an enclosed leaflet or separate professional documentation.

Usage

  • For professional use only; Jalupro Glow Peel must be applied by suitably trained and qualified healthcare or aesthetic professionals.
  • Assess skin type, indications and contraindications before treatment; obtain informed consent and explain expected results and downtime.
  • Cleanse and degrease the treatment area thoroughly, removing all makeup, sunscreen and skincare products.
  • Protect sensitive areas as required (e.g. corners of the mouth, nasal folds, eye area) with barrier ointment, according to protocol.
  • Apply an appropriate amount of Jalupro Glow Peel solution evenly to the treatment area using a suitable applicator (brush, cotton tip or gauze), following the manufacturer’s recommended layer thickness and exposure time.
  • Monitor the skin response throughout application (erythema, frosting, patient sensation) and adjust contact time according to skin type, indication and tolerance.
  • After the desired exposure time has elapsed, follow the indicated neutralisation or removal process in the protocol (e.g. rinsing with water or applying a post-peel neutralising product if recommended).
  • Apply post-peel soothing and hydrating products as indicated (e.g. recovery creams, barrier repair products, broad-spectrum SPF 30+).
  • Typical treatment course recommended by manufacturer and clinics: 3–4 sessions at intervals of approximately 2–3 weeks, depending on indication and skin response.
  • Advise the patient to avoid intense sun exposure, heat, saunas, vigorous exercise and exfoliating products for several days post-peel, and to use high-SPF sunscreen daily.
  • Provide written post-treatment instructions including what to expect (mild redness, possible flaking) and when to seek medical advice (unusual pain, swelling, blistering or infection).

Contraindications

  • Known hypersensitivity or allergy to any component of the peel (mandelic acid, lactic acid, salicylic acid, tranexamic acid, resorcinol, amino acids or excipients).
  • Active skin infections, open wounds, dermatitis, rosacea flare, herpes simplex lesions or other significant inflammatory dermatoses in the treatment area.
  • Compromised skin barrier or severe sunburn in the planned treatment zone.
  • History of keloid formation or abnormal scarring, unless carefully evaluated and deemed appropriate by a specialist.
  • Use of isotretinoin in the preceding months (timeframe according to current guidelines and prescriber judgement).
  • Recent aggressive peels, ablative lasers or dermabrasion in the same area that have not fully healed.
  • Pregnancy and breastfeeding, due to limited safety data for this specific peel (use generally not recommended).
  • Known photosensitivity disorders or use of strong photosensitising medications, unless appropriately managed and monitored.
  • Inability or unwillingness to comply with post-peel sun protection and aftercare instructions.

Adverse Effects

  • Expected, transient reactions such as burning or stinging sensation during application, erythema (redness) and warmth immediately after treatment.
  • Post-treatment tightness, dryness and superficial flaking or peeling over several days as the stratum corneum renews.
  • Temporary darkening or lightening of pigmentation in treated areas, particularly in darker skin phototypes if aftercare is not followed.
  • Mild oedema or swelling, especially in sensitive areas such as around the eyes.
  • Less common events include prolonged erythema, post-inflammatory hyperpigmentation or hypopigmentation, especially with inadequate photoprotection.
  • Rare but more serious complications may include blistering, erosions, infection, scarring or persistent pigmentary changes; these require prompt clinical evaluation and management.
  • As with all chemical peels, the risk and severity of adverse effects are influenced by skin type, peel strength, contact time, pre-existing conditions and adherence to post-care instructions.

Storage Conditions

  • Store in a cool, dry place at a controlled temperature, typically between 2 °C and 25 °C (or 2–14 °C as stated by some distributors), according to the manufacturer’s label.
  • Protect vials from direct sunlight and sources of heat.
  • Keep vials in the original outer carton until use to protect from light and contamination.
  • Do not freeze.
  • Use before the expiry date printed on the packaging.
  • Once a vial is opened, use it according to the manufacturer’s instructions and discard any remaining product if single-use is specified.
  • Keep out of reach of children and unauthorised persons.

Duration

Each in-clinic peel session typically takes around 20\u201330 minutes including preparation and post-care. A full treatment cycle usually consists of 3\u20134 sessions spaced at 2\u20133 week intervals, with maintenance peels performed periodically (for example every few months) according to clinical assessment and patient goals.

Onset

Many patients notice increased radiance and smoother texture shortly after the first peel, with progressive improvements in fine lines, pigmentation, acne scarring and overall tone over the full course of 3\u20134 sessions. Mild flaking or peeling may occur for several days after treatment, while optimal visible results generally appear over the following weeks as cell turnover and collagen remodelling continue.

Browse more Aesthetic medicine

Top Treatments

Top Cities in the UK